Last filing: Jan 6, 2026. Most recent sale before this period: Dec 28, 2022.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Dec 28, 2022.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | Director | Jan 31, 2017 | Jan 6, 2026 |
| McKesson Corporation (MCK) | Former Director | May 1, 2014 | Aug 19, 2020 |
| Labcorp (LH) | Former Director | Jan 5, 2011 | Feb 19, 2013 |
| Vertex Pharmaceuticals (VRTX) | Former SVP, Comm. Ops. | Dec 15, 2003 | Jul 22, 2005 |
Also a director at
McKesson Corporation (MCK) (no filing in the last 18 months), Labcorp (LH) (no filing in the last 18 months)
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 2, 2026, Regeneron Pharmaceuticals: 155 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.